This operating performance led to earnings of $1.15 per diluted share, up 37% over the second quarter of 2020 and above our guidance range of $1.08 to $1.10.
Overall sales were a record $1.39 billion, up 37% over the same period in 2020.
For the full year, we now expect overall sales to be up approximately 20% and organic sales up approximately 10% over 2020.
For the third quarter, we anticipate that overall sales will be up in the mid-20% range versus the same period last year.
For 2021, we continue to expect our effective tax rate to be between 19% and 20%.
Diluted earnings per share for 2021 are now expected to be in the range of $4.62 to $4.68, an increase of 17% to 18% over 2020's comparable basis and above our prior guide of $4.48 to $4.56 per diluted share.
For the full year, we now expect overall sales to be up approximately 20% and organic sales up approximately 10% over 2020.
For the third quarter, we anticipate that overall sales will be up in the mid-20% range versus the same period last year.
For 2021, we continue to expect our effective tax rate to be between 19% and 20%.
Third quarter earnings per diluted share are now expected to be between $1.16 to $1.18, up 15% to 17% over last year's third quarter.
